Olivier Ledanois, n/a

Senior Global Medical Director Asthma
Sanofi Winthrop Industrie, France

Poster(s):

• (411) Real-world outcomes after 2 years of dupilumab therapy for severe asthma: the ProVENT study
  Wednesday, October 29, 2025